By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet ...

The failure to enact a proposed 10-year moratorium on state AI regulations brings meaningful clarity for employers, according ...

Drug industry regulators are embracing AI to streamline their oversight activities, but the plan for how they will do this is ...

Agentic AI platform built for government interaction gives policy and legal teams leverage to move faster, stay ahead of the ...

Siemens and SAP CEOs have urged the European Union to revise its artificial intelligence legislation, saying the current ...

The nuclear industry is a prime target for the use of machine learning and artificial intelligence (AI) and there are ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...

The praise came at the conclusion of a 12-day Integrated Regulatory Review Service (IRRS) mission to China on 11 July 2025, ...